Subramanian Sanjay 4
4 · Inozyme Pharma, Inc. · Filed Mar 15, 2024
Insider Transaction Report
Form 4
Subramanian Sanjay
SVP, CFO & Head of BD
Transactions
- Award
Stock Option (right to buy)
2024-03-13+165,000→ 165,000 totalExercise: $5.77Exp: 2034-03-12→ Common Stock (165,000 underlying)
Footnotes (1)
- [F1]The option was granted on March 13, 2024 and is scheduled to vest in equal monthly installments until the fourth anniversary of the grant date.